Rage-induced cytosolic ROS promote mitochondrial superoxide generation in diabetes

Journal of the American Society of Nephrology

Volumn 20, Issue 4, 2009, Pages 742-752

  Coughlan, Melinda T ^a   Thorburn, David R ^b   Penfold, Sally A ^a   Laskowski, Adrienne ^b   Harcourt, Brooke E ^a   Sourris, Karly C ^a   Tan, Adeline L Y ^a   Fukami, Kei ^a   Thallas Bonke, Vicki ^a   Nawroth, Peter P ^c   Brownlee, Michael ^d   Bierhaus, Angelika ^c   Cooper, Mark E ^a   Forbes, Josephine M ^a  

^a BAKER IDI HEART AND DIABETES INSTITUTE   (Australia)

^b UNIVERSITY OF MELBOURNE   (Australia)

^c UNIVERSITY OF HEIDELBERG   (Germany)

^d ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOVIRUS VECTOR; ADVANCED GLYCATION END PRODUCT; ADVANCED GLYCATION END PRODUCT RECEPTOR; ALAGEBRIUM; GLUCOSE; REACTIVE OXYGEN METABOLITE; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE DEHYDROGENASE (UBIQUINONE); SUPEROXIDE;

ANIMAL EXPERIMENT; ANIMAL MODEL; APOPTOSIS; ARTICLE; CONTROLLED STUDY; CYTOSOL; DIABETES MELLITUS; DIABETIC NEPHROPATHY; ENZYME SUBSTRATE; GENE OVEREXPRESSION; GLUCOSE BLOOD LEVEL; HYPERGLYCEMIA; IN VIVO STUDY; KIDNEY CELL; KIDNEY CORTEX; MALE; MITOCHONDRIAL MEMBRANE POTENTIAL; MITOCHONDRIAL PERMEABILITY; MITOCHONDRION; NONHUMAN; NUCLEOTIDE SEQUENCE; OXIDATIVE STRESS; PRIORITY JOURNAL; PROTEIN PROTEIN INTERACTION; RAT; TISSUE INJURY;

EID: 65249153029     PISSN: 10466673     EISSN: 15333450     Source Type: Journal    
DOI: 10.1681/ASN.2008050514     Document Type: Article

References (44)

1. Pitkanen S, Robinson BH: Mitochondrial complex I deficiency leads to increased production of superoxide radicals and induction of superoxide dismutase. J Clin Invest 98: 345-351, 1996
2. Nishikawa T, Edelstein D, Du XL, Yamagishi S, Matsumura T, Kaneda Y, Yorek MA, Beebe D, Oates PJ, Hammes HP, Giardino I, Brownlee M: Normalizing mitochondrial superoxide production blocks three pathways of hyperglycaemic damage. Nature 404: 787-790, 2000
3. Baynes JW, Thorpe SR: Role of oxidative stress in diabetic complications: A new perspective on an old paradigm. Diabetes 48: 1-9, 1999
4. Koopman WJ, Verkaart S, Visch HJ, van der Westhuizen FH, Murphy MP, van den Heuvel LW, Smeitink JA, Willems PH: Inhibition of complex I of the electron transport chain causes O2 -.-mediated mitochondrial outgrowth. Am J Physiol Cell Physiol 288: C1440-C1450, 2005
5. Beyer RE: An analysis of the role of coenzyme Q in free radical generation and as an antioxidant. Biochem Cell Biol 70: 390-403, 1992
6. Rotig A, de Lonlay P, Chretien D, Foury F, Koenig M, Sidi D, Munnich A, Rustin P: Aconitase and mitochondrial iron-sulphur protein deficiency in Friedreich ataxia. Nat Genet 17: 215-217, 1997
7. Martin-Hernandez E, Garcia-Silva MT, Vara J, Campos Y, Cabello A, Muley R, Del Hoyo P, Martin MA, Arenas J: Renal pathology in children with mitochondrial diseases. Pediatr Nephrol 20: 1299-1305, 2005
8. Singh PJ, Santella RN, Zawada ET: Mitochondrial genome mutations and kidney disease. Am J Kidney Dis 28: 140-146, 1996
9. Rosca MG, Mustata TG, Kinter MT, Ozdemir AM, Kern TS, Szweda LI, Brownlee M, Monnier VM, Weiss MF: Glycation of mitochondrial proteins from diabetic rat kidney is associated with excess superoxide formation. Am J Physiol Renal Physiol 289: F420-F430, 2005
10. Oliveira PJ, Esteves TC, Seica R, Moreno AJ, Santos MS: Calcium- dependent mitochondrial permeability transition is augmented in the kidney of Goto-Kakizaki diabetic rat. Diabetes Metab Res Rev 20: 131-136, 2004
11. Batandier C, Leverve X, Fontaine E: Opening of the mitochondrial permeability transition pore induces reactive oxygen species production at the level of the respiratory chain complex I. J Biol Chem 279: 17197-17204, 2004
12. Kabat A, Ponicke K, Salameh A, Mohr FW, Dhein S: Effect of a beta 2-adrenoceptor stimulation on hyperglycemia-induced endothelial dysfunction. J Pharmacol Exp Ther 308: 564-573, 2004
13. Brownlee M: Biochemistry and molecular cell biology of diabetic complications. Nature 414: 813-820, 2001
14. Forbes JM, Thallas V, Thomas MC, Founds HW, Burns WC, Jerums G, Cooper ME: The breakdown of preexisting advanced glycation end products is associated with reduced renal fibrosis in experimental diabetes. FASEB J 17: 1762-1764, 2003
15. Wendt TM, Tanji N, Guo J, Kislinger TR, Qu W, Lu Y, Bucciarelli LG, Rong LL, Moser B, Markowitz GS, Stein G, Bierhaus A, Liliensiek B, Arnold B, Nawroth PP, Stern DM, D'Agati VD, Schmidt AM: RAGE drives the development of glomerulosclerosis and implicates podo- cyte activation in the pathogenesis of diabetic nephropathy. Am J Pathol 162: 1123-1137, 2003
16. Basta G, Lazzerini G, Del Turco S, Ratto GM, Schmidt AM, De Caterina R: At least 2 distinct pathways generating reactive oxygen species mediate vascular cell adhesion molecule-1 induction by advanced glycation end products. Arterioscler Thromb Vasc Biol 25: 1401-1407, 2005
17. Cai W, He JC, Zhu L, Lu C, Vlassara H: Advanced glycation end product (AGE) receptor 1 suppresses cell oxidant stress and activation signaling via EGF receptor. Proc Natl Acad Sci U S A 103: 1380113806, 2006
18. Degenhardt TP, Alderson NL, Arrington DD, Beattie RJ, Basgen JM, Steffes MW, Thorpe SR, Baynes JW: Pyridoxamine inhibits early renal disease and dyslipidemia in the streptozotocin-diabetic rat. KidneyInt 61: 939-950, 2002
19. Oldfield MD, Bach LA, Forbes JM, Nikolic-Paterson D, McRobert A, Thallas V, Atkins RC, Osicka T, Jerums G, Cooper ME: Advanced glycation end products cause epithelial-myofibroblast transdifferen- tiation via the receptor for advanced glycation end products (RAGE). J Clin Invest 108: 1853-1863, 2001
20. Broekemeier KM, Dempsey ME, Pfeiffer DR: Cyclosporin A is a potent inhibitor of the inner membrane permeability transition in liver mitochondria. J Biol Chem 264: 7826-7830, 1989
21. Crompton M, Ellinger H, Costi A: Inhibition by cyclosporin A of a Ca2+-dependent pore in heart mitochondria activated by inorganic phosphate and oxidative stress. Biochem J 255: 357-360, 1988
22. Fournier N, Ducet G, Crevat A: Action of cyclosporine on mitochon- drial calcium fluxes. J Bioenerg Biomembr 19: 297-303, 1987
23. Brunt KR, Fenrich KK, Kiani G, Tse MY, Pang SC, Ward CA, Melo LG: Protection ofhuman vascular smooth muscle cells from H2O2-induced apoptosis through functional codependence between HO-1 and AKT. Arterioscler Thromb Vasc Biol 26: 2027-2034, 2006
24. Wautier MP, Chappey O, Corda S, Stern DM, Schmidt AM, Wautier JL: Activation of NADPH oxidase by AGE links oxidant stress to altered gene expression via RAGE. Am J Physiol Endocrinol Metab 280: E685-E694, 2001
25. Thallas-Bonke V, Thorpe SR, Coughlan MT, Fukami K, Yap FY, Sourris KC, Penfold SA, Bach LA, Cooper ME, Forbes JM: Inhibition of NADPH oxidase prevents advanced glycation end product-mediated damage in diabetic nephropathy through a protein kinase C-alpha- dependent pathway. Diabetes 57: 460-469, 2008
26. Colell A, Garcia-Ruiz C, Mari M, Fernandez-Checa JC: Mitochondrial permeability transition induced by reactive oxygen species is independent of cholesterol-regulated membrane fluidity. FEBS Lett 560: 63-68, 2004
27. Takeyama N, Miki S, Hirakawa A, Tanaka T: Role of the mitochondrial permeability transition and cytochrome C release in hydrogen peroxide-induced apoptosis. Exp Cell Res 274: 16-24, 2002
28. Liu X, Kim CN, Yang J, Jemmerson R, Wang X: Induction of apoptotic program in cell-free extracts: Requirement for dATP and cytochrome c. Cell 86: 147-157, 1996
29. Weissgarten J, Berman S, Efrati S, Rapoport M, Averbukh Z, Feldman L: Apoptosis and proliferation of cultured mesangial cells isolated from kidneys of rosiglitazone-treated pregnant diabetic rats. Nephrol Dial Transplant 21: 1198-1204, 2006
30. Chuang PY, Yu Q, Fang W, Uribarri J, He JC: Advanced glycation endproducts induce podocyte apoptosis by activation of the FOXO4 transcription factor. Kidney Int 72: 965-976, 2007
31. Isermann B, Vinnikov IA, Madhusudhan T, Herzog S, Kashif M, Blautzik J, Corat MA, Zeier M, Blessing E, Oh J, Gerlitz B, Berg DT, Grinnell BW, Chavakis T, Esmon CT, Weiler H, Bierhaus A, Nawroth PP: Activated protein C protects against diabetic nephropathy by inhibiting endothelial and podocyte apoptosis. Nat Med 13: 1349-1358, 2007
32. Susztak K, RaffAC, Schiffer M, Bottinger EP: Glucose-induced reactive oxygen species cause apoptosis of podocytes and podocyte depletion at the onset of diabetic nephropathy. Diabetes 55: 225-233, 2006
33. Wang W, Fang H, Groom L, Cheng A, Zhang W, Liu J, Wang X, Li K, Han P, Zheng M, Yin J, Wang W, Mattson MP, Kao JP, Lakatta EG, Sheu SS, Ouyang K, Chen J, Dirksen RT, Cheng H: Superoxide flashes in single mitochondria. Cell 134: 279-290, 2008
34. Coughlan MT, Thallas-Bonke V, Pete J, Long DM, Gasser A, Tong DC, Arnstein M, Thorpe SR, Cooper ME, Forbes JM: Combination therapy with the advanced glycation end product cross-link breaker, alage- brium, and angiotensin converting enzyme inhibitors in diabetes: Synergy or redundancy? Endocrinology 148: 886-895, 2007
35. Bierhaus A, Haslbeck KM, Humpert PM, Liliensiek B, Dehmer T, Mor- cos M, Sayed AA, Andrassy M, Schiekofer S, Schneider JG, Schulz JB, Heuss D, Neundörfer B, Dierl S, Huber J, Tritschler H, Schmidt AM, Schwaninger M, Haering HU, Schleicher E, Kasper M, Stern DM, Arnold B, Nawroth PP: Loss of pain perception in diabetes is dependent on a receptor of the immunoglobulin superfamily. J Clin Invest 114: 1741-1751, 2004
36. Constien R, Forde A, Liliensiek B, Gröne HJ, Nawroth P, Hämmerling G, Arnold B: Characterization of a novel EGFP reporter mouse to monitor Cre recombination as demonstrated by a Tie2 Cre mouse line. Genesis 30: 36-44, 2001
37. Forbes JM, Yee LTL, Thallas V, Lassila M, Candido R, Jandeleit-Dahm K, Thomas MC, Burns WC, Deemer E, Thorpe SR, Cooper ME, Allen TJ: Advanced glycation end product interventions reduce diabetes accelerated atherosclerosis. Diabetes 53: 1813-1823, 2004
38. Vlassara H, Striker LJ, Teichberg S, Fuh H, Li YM, Steffes M: Advanced glycation end products induce glomerular sclerosis and albuminuria in normal rats. Proc Natl Acad Sci U S A 91: 11704-11708, 1994
39. Yonekura H, Yamamoto Y, Sakurai S, Petrova RG, Abedin MJ, Li H, Yasui K, Takeuchi M, Makita Z, Takasawa S, Okamoto H, Watanabe T, Yamamoto H: Novel splice variants of the receptor for advanced glycation end-products expressed in human vascular endothelial cells and pericytes, and their putative roles in diabetes-induced vascular injury. Biochem J 370: 1097-1109, 2003
40. Schulze-Lohoff E, Hugo C, Rost S, Arnold S, Gruber A, Brüne B, Sterzel RB: Extracellular ATP causes apoptosis and necrosis of cultured mes- angial cells via P2Z/P2X7 receptors. Am J Physiol 275: F962-F971, 1998
41. Schlondorff D: Preparation and study of isolated glomeruli. Methods Enzymol 191: 130-140, 1990
42. Rahman S, Blok RB, Dahl HH, Danks DM, Kirby DM, Chow CW, Christodoulou J, Thorburn DR: Leigh syndrome: Clinical features and biochemical and DNA abnormalities. Ann Neurol 39: 343-351, 1996
43. Thorburn DR, Sugiana C, Salemi R, Kirby DM, Worgan L, Ohtake A, Ryan MT: Biochemical and molecular diagnosis of mitochondrial respiratory chain disorders. Biochim Biophys Acta 1659: 121-128, 2004
44. Nisselbaum JS, Green S: A simple ultramicro method for determination of pyridine nucleotides in tissues. Anal Biochem 27: 212-217, 969